222 related articles for article (PubMed ID: 27288807)
1. Investigation of serum levels and tissue expression of two genes IGFBP-2 and IGFBP-3 act as potential biomarker for predicting the progression and survival in patients with glioblastoma multiforme.
Abdolhoseinpour H; Mehrabi F; Shahraki K; Khoshnood RJ; Masoumi B; Yahaghi E; Goudarzi PK
J Neurol Sci; 2016 Jul; 366():202-206. PubMed ID: 27288807
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic and prognostic value of preoperative combined GFAP, IGFBP-2, and YKL-40 plasma levels in patients with glioblastoma.
Gállego Pérez-Larraya J; Paris S; Idbaih A; Dehais C; Laigle-Donadey F; Navarro S; Capelle L; Mokhtari K; Marie Y; Sanson M; Hoang-Xuan K; Delattre JY; Mallet A
Cancer; 2014 Dec; 120(24):3972-80. PubMed ID: 25139333
[TBL] [Abstract][Full Text] [Related]
3. Plasma IGFBP-2 levels predict clinical outcomes of patients with high-grade gliomas.
Lin Y; Jiang T; Zhou K; Xu L; Chen B; Li G; Qiu X; Jiang T; Zhang W; Song SW
Neuro Oncol; 2009 Oct; 11(5):468-76. PubMed ID: 19164435
[TBL] [Abstract][Full Text] [Related]
4. Grade-specific expression of insulin-like growth factor-binding proteins-2, -3, and -5 in astrocytomas: IGFBP-3 emerges as a strong predictor of survival in patients with newly diagnosed glioblastoma.
Santosh V; Arivazhagan A; Sreekanthreddy P; Srinivasan H; Thota B; Srividya MR; Vrinda M; Sridevi S; Shailaja BC; Samuel C; Prasanna KV; Thennarasu K; Balasubramaniam A; Chandramouli BA; Hegde AS; Somasundaram K; Kondaiah P; Rao MR
Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1399-408. PubMed ID: 20501753
[TBL] [Abstract][Full Text] [Related]
5. STAT-1 expression is regulated by IGFBP-3 in malignant glioma cells and is a strong predictor of poor survival in patients with glioblastoma.
Thota B; Arimappamagan A; Kandavel T; Shastry AH; Pandey P; Chandramouli BA; Hegde AS; Kondaiah P; Santosh V
J Neurosurg; 2014 Aug; 121(2):374-83. PubMed ID: 24878287
[TBL] [Abstract][Full Text] [Related]
6. Gene expression profiling in glioblastoma and immunohistochemical evaluation of IGFBP-2 and CDC20.
Marucci G; Morandi L; Magrini E; Farnedi A; Franceschi E; Miglio R; Calò D; Pession A; Foschini MP; Eusebi V
Virchows Arch; 2008 Dec; 453(6):599-609. PubMed ID: 18953566
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic and prognostic value of stem cell factor plasma level in glioblastoma multiforme patients.
Kefayat A; Amouheidari A; Ghahremani F; Alirezaei Z
Cancer Med; 2021 Aug; 10(15):5154-5162. PubMed ID: 34250760
[TBL] [Abstract][Full Text] [Related]
8. Polysialic acid neural cell adhesion molecule (PSA-NCAM) is an adverse prognosis factor in glioblastoma, and regulates olig2 expression in glioma cell lines.
Amoureux MC; Coulibaly B; Chinot O; Loundou A; Metellus P; Rougon G; Figarella-Branger D
BMC Cancer; 2010 Mar; 10():91. PubMed ID: 20219118
[TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor binding protein-2 regulates β-catenin signaling pathway in glioma cells and contributes to poor patient prognosis.
Patil SS; Gokulnath P; Bashir M; Shwetha SD; Jaiswal J; Shastry AH; Arimappamagan A; Santosh V; Kondaiah P
Neuro Oncol; 2016 Nov; 18(11):1487-1497. PubMed ID: 27044294
[TBL] [Abstract][Full Text] [Related]
10. Silencing of insulin-like growth factor-binding protein-2 in human glioblastoma cells reduces both invasiveness and expression of progression-associated gene CD24.
Fukushima T; Tezuka T; Shimomura T; Nakano S; Kataoka H
J Biol Chem; 2007 Jun; 282(25):18634-18644. PubMed ID: 17475624
[TBL] [Abstract][Full Text] [Related]
11. Expression patterns of insulin-like growth factor binding protein isoforms in medulloblastoma subtypes and clinical correlation.
Narayan R; Shastry AH; Thota B; Sampath S; Thennarasu K; Arivazhagan A; Santosh V
Pediatr Neurosurg; 2013; 49(6):325-30. PubMed ID: 25427587
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor binding protein-2 and glucose-regulated protein 78 kDa: Potential biomarkers affect prognosis in IDH-wildtype glioblastoma patients.
Harland AJ; Perks CM; White P; Kurian KM; Barber HR
Cancer Med; 2023 Jul; 12(13):14426-14439. PubMed ID: 37212470
[TBL] [Abstract][Full Text] [Related]
13. Plasma IGFBP-2 levels after postoperative combined radiotherapy and chemotherapy predict prognosis in elderly glioblastoma patients.
Han S; Meng L; Han S; Wang Y; Wu A
PLoS One; 2014; 9(4):e93791. PubMed ID: 24690948
[TBL] [Abstract][Full Text] [Related]
14. Assessing the clinical utility of measuring Insulin-like Growth Factor Binding Proteins in tissues and sera of melanoma patients.
Yu JZ; Warycha MA; Christos PJ; Darvishian F; Yee H; Kaminio H; Berman RS; Shapiro RL; Buckley MT; Liebes LF; Pavlick AC; Polsky D; Brooks PC; Osman I
J Transl Med; 2008 Nov; 6():70. PubMed ID: 19025658
[TBL] [Abstract][Full Text] [Related]
15. In vivo expression of insulin-like growth factor-binding protein-2 in human gliomas increases with the tumor grade.
Elmlinger MW; Deininger MH; Schuett BS; Meyermann R; Duffner F; Grote EH; Ranke MB
Endocrinology; 2001 Apr; 142(4):1652-8. PubMed ID: 11250947
[TBL] [Abstract][Full Text] [Related]
16. High expression of estrogen receptor alpha and aromatase in glial tumor cells is associated with gender-independent survival benefits in glioblastoma patients.
Hönikl LS; Lämmer F; Gempt J; Meyer B; Schlegel J; Delbridge C
J Neurooncol; 2020 May; 147(3):567-575. PubMed ID: 32240464
[TBL] [Abstract][Full Text] [Related]
17. BRCA1 Protein Expression Predicts Survival in Glioblastoma Patients from an NRG Oncology RTOG Cohort.
Vassilakopoulou M; Won M; Curran WJ; Souhami L; Prados MD; Langer CJ; Rimm DL; Hanna JA; Neumeister VM; Melian E; Diaz AZ; Atkins JN; Komarnicky LT; Schultz CJ; Howard SP; Zhang P; Dicker AP; Knisely JPS
Oncology; 2021; 99(9):580-588. PubMed ID: 33957633
[TBL] [Abstract][Full Text] [Related]
18. Prognostic relevance of NG2/CSPG4, CD44 and Ki-67 in patients with glioblastoma.
Tsidulko AY; Kazanskaya GM; Kostromskaya DV; Aidagulova SV; Kiselev RS; Volkov AM; Kobozev VV; Gaitan AS; Krivoshapkin AL; Grigorieva EV
Tumour Biol; 2017 Sep; 39(9):1010428317724282. PubMed ID: 28945172
[TBL] [Abstract][Full Text] [Related]
19. Carbonic anhydrase IX is a prognostic biomarker in glioblastoma multiforme.
Cetin B; Gonul II; Gumusay O; Bilgetekin I; Algin E; Ozet A; Uner A
Neuropathology; 2018 Oct; 38(5):457-462. PubMed ID: 29952031
[TBL] [Abstract][Full Text] [Related]
20. The relationship of erythropoietin receptor expression and prognosis in glioblastoma multiforme patients.
Cevik S; Kitis S; Evran S; Akkaya E; Tosuner Z; Hanimoglu H
Niger J Clin Pract; 2018 Apr; 21(4):502-506. PubMed ID: 29607865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
